Laverock Therapeutics jobs and careers
About Laverock Therapeutics
Laverock Therapeutics is developing a gene silencing platform for the creation of programmable, allogeneic cell therapies.
- Founded
- 2022
- Employees
- 11 to 50
- Total funding
- $14.5M
Leadership
The top of Laverock Therapeutics's org chart, with how many people report into each leader.
DV
David Venables
CEO
19 reports
VS
Vlad Seitan
Chief Scientific Officer
14 reports
SM
Sandy McDougall
Chief Financial Officer
1 report
TP
Tom Payne
Chief Operating Officer
TA
Tim Allsopp
CTO
Jobs at Laverock Therapeutics
No open positions right now. Explore more companies on TheJobsMap.